Comparison of clinical and MRI features of hepatic angiosarcoma and epithelioid hemangioendothelioma

被引:0
|
作者
Kim, Hae Young [1 ]
Hong, Sun [2 ]
Heo, Subin [1 ]
Song, In Hye [5 ]
Kim, Jihun [5 ]
Yoo, Youngeun [6 ]
Kang, Hyo Jeong [5 ]
Park, Seong Ho [3 ,4 ]
Lee, Seung Soo [3 ,4 ]
Kim, So Yeon [3 ,4 ]
机构
[1] Asan Med Ctr, Dept Radiol, Seoul, South Korea
[2] Korea Univ, Coll Med, Ansan Hosp, Dept Radiol, Ansan, South Korea
[3] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Radiol, Seoul, South Korea
[4] Univ Ulsan, Res Inst Radiol, Coll Med, Asan Med Ctr, Seoul, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea
[6] Ewha Womans Univ, Seoul Hosp, Coll Med, Dept Pathol, Seoul, South Korea
关键词
Magnetic resonance imaging; Angiosarcoma; Epithelioid hemangioendothelioma; Survival; LIVER; CT;
D O I
10.1007/s00261-024-04513-3
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective Differentiating hepatic epithelioid hemangioendothelioma (EHE) and angiosarcoma (AS), the two most common vascular tumors in the liver, is important due to disparities in their prognosis and treatment. We aimed to compare clinical and MRI features of the two tumors. Methods This retrospective study included patients with pathologically-confirmed AS or EHE who underwent MRI using gadoxetate disodium between 2008 and 2023. Two radiologists independently reviewed MR images. Wilcoxon rank sum and Fisher's exact tests were used to compare clinical and imaging features. Overall survival was compared using restricted mean survival time at 3 years. Results 32 patients with AS (18 women [56.3%]; median age, 68 years) and 38 with EHE (24 women [63.2%]; 51 years) were included. Patients with AS were generally older (81.3% >= 60 years; P < 0.001), had more frequent laboratory abnormalities (P <= 0.018), and poorer overall survival (11.2 vs. 31.8 months; P < 0.001) than those with EHE. On MRI, a large dominant mass accompanied by smaller nodules (14/32, 43.8%), often with ill-defined margins (15/32, 46.9%) was prevalent in AS; compared with nodules of similar sizes (24/38, 63.2%; P = 0.015) with well-defined margin (30/38, 78.9%; P = 0.002) in EHE. Cirrhotic appearance of the liver was more frequent in AS (62.5%, P < 0.001), along with decreased parenchymal enhancement on hepatobiliary phase (31.3%, P < 0.001) and ascites (37.5%, P = 0.010). AS frequently presented with avid enhancement of bizarrely-shaped foci, with a centrifugal enhancement pattern. In comparison, targetoid appearance was characteristic of EHE (78.9% on T2-weighted, 54.1% on diffusion-weighted, 65.8% on multiphase images) (P <= 0.002), with enhancement degree typically lower than that of the aorta. On hepatobiliary phase, all the AS exhibited hypointensity, while 39.5% of EHE showed targetoid appearance (P < 0.001). Conclusion Patients aged >= 60 years presenting with laboratory abnormalities, typically with a large dominant mass accompanied by smaller nodules, exhibiting avid, bizarre, and centrifugal enhancement-particularly in the cirrhotic-appearing liver-suggests the likelihood of AS over EHE.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Comparison of the clinical and MRI features of patients with hepatic hemangioma, epithelioid hemangioendothelioma, or angiosarcoma
    Liu, Zhuangsheng
    Yi, Lilei
    Chen, Junhao
    Li, Ruqiong
    Liang, Keming
    Chen, Xiangmeng
    Li, Ronggang
    Long, Wansheng
    [J]. BMC MEDICAL IMAGING, 2020, 20 (01)
  • [2] Comparison of the clinical and MRI features of patients with hepatic hemangioma, epithelioid hemangioendothelioma, or angiosarcoma
    Zhuangsheng Liu
    Lilei Yi
    Junhao Chen
    Ruqiong Li
    Keming Liang
    Xiangmeng Chen
    Ronggang Li
    Wansheng Long
    [J]. BMC Medical Imaging, 20
  • [3] Clinicopathological and cytogenetic features of hepatic angiosarcoma and epithelioid hemangioendothelioma
    Wang, Zhan-Bo
    Liu, Jin-Hong
    Yuan, Jing
    Shi, Huai-Yin
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (12): : 12470 - 12480
  • [4] Hepatic angiosarcoma mimicking hepatic epithelioid hemangioendothelioma: report of a case
    Hiroaki Shiba
    Taro Sakamoto
    Tomonori Iida
    Kenei Furukawa
    Koichiro Haruki
    Katsuhiko Yanaga
    [J]. International Cancer Conference Journal, 2017, 6 (1) : 29 - 34
  • [5] Novel and Specific MRI Features Indicate the Clinical Features of Patients With Rare Hepatic Tumor Epithelioid Hemangioendothelioma
    Zhang, Wei
    Zhang, Hongtao
    Zhong, Yanwei
    Zhang, Keming
    Kong, Huifang
    Yu, Linxiang
    Chen, Yan
    Bai, Yili
    Zhu, Zhenyu
    Yang, Yongping
    Gao, Xudong
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] MRI of Hepatic Epithelioid Hemangioendothelioma (HEH)
    Paolantonio, Pasquale
    Laghi, Andrea
    Vanzulli, Angelo
    Grazioli, Luigi
    Morana, Gianni
    Ragozzino, Alfonso
    Colagrande, Stefano
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2014, 40 (03) : 552 - 558
  • [7] MRI findings of a hepatic epithelioid hemangioendothelioma
    Lv, Peng
    Lin, Jiang
    [J]. QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2012, 2 (03) : 237 - 238
  • [8] Cytopathologic features of hepatic epithelioid hemangioendothelioma
    Soslow, RA
    Yin, P
    Steinberg, CR
    Yang, GCH
    [J]. DIAGNOSTIC CYTOPATHOLOGY, 1997, 17 (01) : 50 - 53
  • [9] Hepatic Epithelioid Hemangioendothelioma: Difficult Differential Diagnosis from Angiosarcoma
    Taniai, Tomohiko
    Onda, Shinji
    Sato, Shun
    Shiba, Hiroaki
    Sakamoto, Taro
    Yanaga, Katsuhiko
    [J]. CASE REPORTS IN GASTROENTEROLOGY, 2020, 14 (01) : 56 - 62
  • [10] CT and MRI diagnosis of hepatic epithelioid hemangioendothelioma
    Lin, Jiang
    Ji, Yuan
    [J]. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2010, 9 (02) : 154 - 158